NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 0.7643 Delayed Data As of Dec 01 |  +0.0174 / +2.33%Today’s Change | 0.60 Today|||52-Week Range 5.82 | -84.77% Year-to-Date |
Latest NGM News | Press Releases
No recent news for NGM Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 0.75 |
| Today’s open | 0.73 |
| Day’s range | 0.73 - 0.76 |
| Volume | 4,778 |
| Average volume (3 months) | 435,263 |
| Market cap | $59.7M |
Data as of 3:57pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -30.33% |
| Earnings growth (this year) | +6.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.95% |
| P/E ratio | NM |
| Price/Sales | 7.25 |
| Price/Book | 0.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAPTRAPT Therapeutics In... | +1.64 | +11.29% |
| STOKStoke Therapeutics I... | +0.15 | +3.96% |
| ---- | ||
| PSNLPersonalis Inc | -0.06 | -3.92% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $55.3M |
| Annual profit (last year) | -$162.7M |
| Net profit margin | -293.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
